Article

Humoral Immunity and Transcriptome Differences of COVID-19 Inactivated Vaccine and Protein Subunit Vaccine as Third Booster Dose in Human

2022-07-28

Abstract excerpt

Background: Against the background of the severe human health and world economic burden caused by COVID-19, the attenuation of vaccine protection efficacy, and the prevalence of variants of concern (VOCs), the third dose of booster immunization has been put on the agenda.<br><br>Methods: Systems biology approaches can help us gain new perspectives on the characterization of immune responses and the identification...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1acafed9-055f-53a4-b9cd-fe536d02ac7f
DOI: 10.2139/ssrn.4175229

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Humoral Immunity and Transcriptome Differences of COVID-19 Inactivated Vaccine and Protein Subunit Vaccine as Third Booster Dose in HumanDOI 10.2139/ssrn.4175229Read

Immunogenicity and Safety of COVID-19 Booster Vaccination: A Real-World Clinical Trial to Identify the Best Vaccination StratagySemantic proximity Read

Immunogenicity and safety of the homogenous booster shot of a recombinant fusion protein vaccine (V-01) against COVID-19 in healthy adult participants primed with a two-dose regimenSemantic proximity Read

Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profilingSemantic proximity Read

Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescentsSemantic proximity Read

Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2Semantic proximity Read

Ad26.COV2.S priming provides a solid immunological base for mRNA-based COVID-19 booster vaccinationSemantic proximity Read

Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics frameworkSemantic proximity Read

Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated vaccineSemantic proximity Read

Mechanistic model for booster doses effectiveness in healthy, cancer and immunosuppressed patients infected with SARS-CoV-2Semantic proximity Read

Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescentsSemantic proximity Read

Durability of protection post-primary COVID-19 vaccination in the US: matched case-control studySemantic proximity Read

Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccinationSemantic proximity Read